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Abstract. 
Stem cells are known to differentiate in response to chemical and mechanical 
properties of the substrates that they are cultured on. As such, supramolecular 
biomaterials with tuneable properties are well-suited to study stem cell 
differentiation. In this report we demonstrate that metabolites can be identified that 
are selectively depleted during differentiation of perivascular stem cells on 
supramolecular peptide gels of different stiffness. On soft (2 kPa), stiff (15 kPa) and 
rigid (40 kPa)) we observe neuronal, chondrogenic and osteogenic differentiation. By 
analysing concentration variances of >600 metabolites during differentiation on the 
stiff and rigid gels (focusing on chondrogenesis and osteogenesis as regenerative 
targets) we identified that specific lipids, lysophosphatidic acid and cholesterol 
sulphate respectively are significantly depleted. We propose that these metabolites 
are therefore involved in the differentiation process. We subsequently demonstrate 
that these individual lipids can, when fed to standard stem cell cultures, induce 
differentiation towards chondrocyte and osteoblast phenotypes. Our concept exploits 
designed supramolecular biomaterials design as a new strategy for discovery of cell 
directing bioactive metabolites of therapeutic relevance. 
 
Bigger Picture. 
Adult stem cells, such as mesenchymal stem cells and perivascular stem cells 
(pericytes) represent autologous cell types that are excellent candidates for 
regenerative medicine. Controlling the differentiation of these stem cells with drugs, 
including small molecules, is highly desirable to elicit targeted regeneration. 
However, identification of these stem cell inducing molecules is non-trivial and 
rational approaches to discover drugs for achieving reproducible, targeted stem cell 
control remain elusive. Here, we demonstrate the design of supramolecular 
hydrogels that allow targeting of a range of stem cell phenotypes, providing a useful 
platform for discovery of differentiation inducing metabolites. These gels are simple 
in composition, containing a fibre forming aromatic peptide amphiphile, which is co-
assembled with a surfactant-like amphiphile that provides hydrophilic surface 
functionality to the fibres. The stiffness of the gels can be precisely tuned over the 
entire range that is typically associated with stem cell differentiation (0.1-40 kPa). 
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We demonstrate that the gels can be used to direct stem cell differentiation without 
the need for induction media and they are therefore ideally suited to study stem cell 
behaviour –including as drug discovery platforms.  To achieve this, we study the 
cell’s usage of biological small molecules, metabolites, during differentiation and 
select bioactive metabolites that can target bone and cartilage formation 
specifically. This new use of designed supramolecular biomaterials can be envisaged 
to remove serendipity from discovery of metabolites associated with biological 
processes as drug candidates.  
 
eTOC Blurb. 
To facilitate metabolomics analysis of stem cell differentiation, supramolecular 
hydrogels were designed with tuneable stiffness but simple chemical functionality. 
These novel gels facilitate stiffness-tuned stem cell differentiation and could be used 
to survey the usage of biological small molecules during differentiation, with 
potential as drug candidates. We thus identify candidate bioactives targeting bone 
and cartilage formation from perivascular and mesenchymal stem cells opening the 
potential new area of using supramolecular biomaterials as a platform for drug 
discovery. 
 
Introduction. 
As stem cells differentiate in response to their physical and (bio-)chemical 
environment, divergent metabolomic activities and alterations in energy demand 
occur. It is likely that stem cells control their metabolome to help prevent 
spontaneous differentiation1-3. Then, as they differentiate, metabolism alters and 
diverges as the cells ‘activate’1-4. As such, the metabolic activity of the cells may be 
expected to contain specific metabolite depletion patterns that are linked to 
differentiation. If these metabolites can be identified, it may be possible to induce 
differentiation by ‘feeding’ these molecules to stem cell cultures. 
 
Metabolites are of increasing interest in control of cell function and differentiation 
and addition of metabolites to cultures has been shown to e.g. promote monocyte 
to iron-recycling macrophage commitment5. Less, however, is known about key 
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regenerative cell types such as stem cells and the identification of metabolites that 
influence specific cell behaviour is currently challenging. 
 
We theorised that we could use a conceptually new approach, a strategy that firstly 
uses supramolecular biomaterials6-9 to create environments that mimic aspects of 
the extracellular matrix and differentially induce stem cell differentiation, and 
secondly, by using these gels to observe and compare metabolite depletion during 
stem cell differentiation in these gels and finally to test whether bioactive 
metabolites that are uniquely depleted during these differentiation experiments in 
turn  control stem cell differentiation in standard cultures. This approach would 
provide a new use of designed supramolecular biomaterials as a platform to 
accelerate discovery of metabolites as drug candidates.  
 
Using a physical (designed cell environment), rather than the more conventional 
biochemical (use of growth factors), approach to trigger differentiation is ideally 
suited to metabolomics experiments as it avoids changing media formulations to 
control growth and differentiation and thus allows for a direct comparison when 
targeting different lineages.  Indeed, changing media recipes could add significant 
artefact to metabolite analysis. 
 
Several types of physical and chemical cues have been shown to influence 
mesenchymal stem cell (MSC) growth3, 10-12 and differentiation13-17 involving 
especially alterations in surface chemistry, topography and stiffness. In particular for 
ability to target a range of MSC fates, tissue matching of stiffness is of considerable 
interest12, 13, 18-22. MSCs cultured on soft, neural tissue-like, matrices (~2 kPa) show a 
tendency to differentiate toward cells expressing neural markers, when they are 
cultured on surfaces with similar elastic properties to muscle (~10 kPa) they form 
myocytes and when cultured on rigid substrates, mimicking pre-calcified bone (~40 
kPa), MSCs become osteoblasts13.  
 
For the purpose of our work, we seek to control stiffness over a physiological range 
of storage moduli while keeping molecular structures as simple as possible, as even 
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small chemical changes can produce substantial effects in cellular response23. We 
have therefore developed hydrogels composed of fibers with simple cytocompatible 
surface functionality24 and tuneable network densities. The gels are well suited to 
cell culture as they are prepared from free-flowing precursor solutions which gelate 
upon exposure to calcium ions present in culture media. The materials ideally fit 
with our desire to keep the cell growth conditions as chemically identical as possible 
so as not to bias the metabolomics experiments. 
 
Thus, we firstly set out to develop simple stiffness-matched gels that are able to 
drive stem cell differentiation. We then use data mining from global metabolomics 
experiments to allow identification of endogenous, individual, bioactive metabolites. 
We specifically look for bioactive metabolites that are depleted when comparing 
differentiation in different gels. Finally, thus identified metabolites are fed to stem 
cell cultures to assess their ability to control and direct differentiation.  
 
Results. 
Formulation and characterisation of varying stiffness gels with minimal chemical 
differences.  
The first objective was to produce chemically similar, cytocompatible hydrogels with 
varying stiffness in the physiologically relevant range to enable step 1, use tissue-
matched gels to drive stem cell differentiation.  
 
Hydrogels are well suited for the production of cell-matched environments. Stiffness 
control of polymeric hydrogels is typically achieved using differential chemical 
crosslinking13, 14. Supramolecular hydrogels7,8, 25,26,27, however, provide an alternative 
approach where stiffness and chemical composition can be systematically varied. 
Most gels studied to date include bioactive groups, typically introduced through 
coating of the substrate with extracellular matrix components or by chemical 
functionalization with bioactive groups (e.g. proteins or peptide motifs)28-30  
 
In order to tailor suitable materials, we made use of a two-component co-assembly 
approach comprising a peptide based gelator (the structural element) and a 
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surfactant-like molecule that presents carboxylate functionality to the surface of 
fibres31, enabling subsequent cross-linking upon exposure to divalent cations (Ca2+) 
present in tissue culture media. Specifically, when fluorenyl-9-methoxycarbonyl-
diphenylalanine, Fmoc-F224, 32, 33 was co-assembled with surfactant-like Fmoc-serine 
(Fmoc-S), the polar serine side chains were presented at the surface of the fibres (Fig 
1a). The differential organisation of the gelator and surfactant components in 
isolation is evident from atomic force microscopy images (Fig 1b) and static light 
scattering (Supplemental Fig 1a), with nanofibres and spherical aggregates observed, 
which upon mixing co-assemble as fibres. The mode of self-assembly is further 
supported by fluorescence spectroscopy (Fig 1c) and Fourier transform infrared 
spectroscopy (FTIR) (Fig 1d).  
 
Formation of hydrogels with tuneable stiffness was achieved by varying co-assembly 
concentrations giving rise to viscous liquids in the concentration range 5-40 mM. The 
presence of carboxylate ions at the fibre surface allows for these structures to be 
stabilised and subsequently physically crosslinked by exposure to tissue culture 
media. Gradual exposure to the media is achieved by diffusion through 
semipermeable membrane of cell culture inserts, resulting in gelation within 
approximately 90 minutes.  
 
Oscillatory rheology of the resulting gels revealed elastic moduli of 0.1 kPa up to 40 
kPa with increasing concentration (Fig 1e). In each case, the elastic modulus G′ 
exceeded the viscous modulus G″, indicating that these gels are predominantly 
elastic in nature (Supplemental Fig 1c). The results show that variation of the 
concentration of fibres can result in gels with moduli close to values reported for 
neural, muscle and bone-like tissues34. Note that stiffness values in the literature are 
obtained using various testing methods, and either Young's or storage moduli are 
reported25. Visual examination (Fig 1f) of the gel samples reveals a clear correlation 
in the appearance with the network properties (Supplemental Fig 1d). 
 
FTIR spectroscopy of the gels in D2O solution with salt composition identical to that 
present in culture media (for composition, see methods)35 revealed significant 
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differences in the hydrogen bonding arrangements in pre-gelation mixtures and gels 
with peak broadening observed with increasing concentrations (Supplemental Fig 1 
e&f).  The broadening peak around 1590 cm-1 (COO- stretch) indicates that at least a 
proportion of the C-termini are deprotonated. As expected, the intensities of amide I 
bands increase with concentration as fibre density increases and is more 
pronounced in the gels compared to the starting mixtures. Fluorescence emission 
spectra of the pre-gelation mixtures at increasing concentrations show quenching of 
the monomeric emission (Supplemental Fig 1 g&h) where the excimeric emission 
becomes more pronounced. These results are in agreement with increased fibre 
densities (fibre size, density and roughness and shown in Supplemental Fig 1 i&j). 
Cell attachment to the fibres likely involves absorption of serum proteins from cell 
culture media. Supplemental Fig 2k shows quenching of Fmoc fluorescence in the 
presence of fibronectin, vitronectin and total serum suggesting that the proteins 
interact with the fibres as fluorenyl emission is quenched in the presence of matrix 
proteins.  In the remainder of this report, we use gels at 10, 30 and 40 mmol.L-1, 
denoted as 2 kPa ‘soft’, 15 kPa ‘stiff’ and 40 kPa ‘rigid’. 
 
Analysis of primary pericyte differentiations. 
In this study we use both MSCs and perivascular stem cells (pericytes) to 
demonstrate the generality of our approach. While MSCs hold great regenerative 
potential, autologous cells are available from e.g. iliac crest aspiration in vanishingly 
small numbers. Pericytes are the multipotent progenitors of MSCs and are readily 
available in large numbers from adipose tissue harvested by liposuction36. This 
availability, plus the ability to precisely characterise them, makes them an excellent 
autologous multipotent cell source able to differentiate into cells of the reticular, 
adipose, cartilaginous and bony lineages36.  
Multipotent pericytes (Supplemental Fig 2) cultured on the hydrogel surfaces and 
glass controls were assessed for primary differentiation lineages after 1 week of 
culture using quantitative (q)PCR. These were ascertained as neurogenesis, 
chondrogenesis and osteogenesis respectively through the increased production of 
the markers 3 tubulin (neural protein), SOX9 (sex determining region Y-box 9, 
chondrogenic directing transcription factor) and RUNX2 (runt related transcription 
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factor 2, osteogenic directing transcription factor) (Fig 1g-i, confirmatory data for 
additional neurogenic, myogenic, adiopogenic chondrogenic and osteogenic markers 
shown in Supplemental Fig 3). These data fit well within the established paradigm of 
stiffness directed MSC differentiation with soft gels inducing neural marker 
expression and rigid gels inducing osteogenesis13, 34. At 15 kPa we note expression of 
chondrogenic markers rather than myogenic (myoD, myogenic differentiation factor 
1, a myogenic transcription factor was undetectable by PCR) previously reported in 
the 10 kPa range. This is perhaps because 15 kPa is closer to the stiffness of 
chondrons in which articular chondrocytes reside37 or it may simply be due to 
differences between gel systems used. 
 
Identification of candidate biological molecules. 
Going forwards to identification of candidate biological molecules, we decided to 
focus on chondrogenesis and osteogenesis as key phenotypes classically targeted in 
regenerative medicine and tissue engineering (cartilage/bone repair). The 
intracellular complement of metabolites for cells cultured on each hydrogel surface 
were analysed after 1 and 4 weeks in culture. Liquid chromatography–mass 
spectrometry (LC-MS) analysis of the cell extracts permitted identification of 
individual metabolites of a total of 630-831 putatively identified metabolites. 
Observed changes largely fitted into four classes, amino acid, lipid, carbohydrate and 
nucleotide metabolism (Supplemental Fig 4). Lipids were chosen to focus on as this 
classification tended to show a depletion based profile on the substrates while 
amino acids, carbohydrates and nucleotides tended to become more abundant 
(Supplemental Fig 4). Lipid metabolite heatmap profiles showed a number of 
temporal (2 to 4 week) depletions were occurring. Metabolites were selected using 
the following criteria: (a) consider metabolites that were uniquely depleted upon 
culturing in one of the two stiffness hydrogels and (b) further select by choosing 
from these candidates metabolites that were unique to KEGG (Kyoto encyclopaedia 
of genes and genomes) pathways, i.e. we would not select chondro- and 
osteogenesis candidates from the same KEGG pathway in order to target distinct 
biosynthetic pathways. Using this methodology, a lysophosphatidic acid (1-
octadecanoyl-sn-glycero-3-phosphate, GP18:0) belonging to the glycerolipid 
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pathway and cholesterol sulphate belonging to the steroid biosynthesis pathway 
were selected (Fig 2). We note that there are likely to be other interesting 
candidates in the pool of metabolites assessed. All lipid changes are shown in 
Supplemental Figs 5&6 and the full data set of depletion patterns is available (see 
materials and methods for DOI link). 
 
Having identified these two metabolites, we considered their likely relevance in 
known cell type-specific processes. Lysophosphatidic acids (LPAs) such as GP18:0 can 
act via membrane bound G-protein coupled receptors and have been shown to 
regulate the mitogen activated protein kinases (MAPKs), more specifically 
extracellular signal-regulated kinase (ERK) pathways that are central in cell growth 
and differentiation38. Further, there is emerging evidence that murine cartilaginous 
bone mesenchymal cells express LPA receptors and that LPAs can have effects on 
chondroprogenitor activation as seen in the ATDC5 cell line39 and in primary murine 
chondrocytes40. 
 
Cholesterol sulphate (CS) is a sterol lipid that resides primarily within the cell 
membrane providing structural support. However, CS in its own right can act as a 
regulatory molecule41, 42. Of the selected metabolites, CS was our only candidate that 
fitted into networks generated in Ingenuity pathway analysis® (IPA). On the rigid 
hydrogel, the analysis of metabolite pathways to layer metabolic information with 
known connections to biochemical pathways from pericytes reveals that CS may be 
used in transforming growth factor beta (TGF) signalling as it becomes depleted in 
pericytes (Supplemental Fig 7). The pathway analysis further implicates bone 
morphogenic protein signalling (BMPs are part of the TGF superfamily) - key to 
RUNX2 activation and hence osteogenesis43 and implies ERK, ROCK, integrin 
(adhesion) and actin (cytoskeleton) signalling, tying in well to literature on 
osteogenesis3, 13, 16, 17.  
 
Testing biological molecule defined differentiation efficacy.  
Having identified small molecules that potentially have roles in stem cell 
differentiation, we moved on to test their ability to direct differentiation. Due to the 
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expected central role in metabolic pathways we studied effects on both MSCs and 
pericytes. Testing of differentiation potential with serial dilutions (Supplemental Fig 
8) revealed concentrations where effects on transcript expression were maximal.  
 
To test osteogenesis and chondrogenesis, both pericytes and MSCs were cultured 
with 1 µM CS and 0.1 µm GP 18:0 in basic media (10% FCS/DMEM) on glass 
coverslips. For testing of osteogenic potential, cells were seeded as standard 
suspension cultures within the full volume of media and allowed to settle and 
adhere across the coverslip surface. For chondrogenic testing, cells were seeded in 
micromass cultures with all the cells being placed on the surface in a small, 20 µl, 
droplet of media and being allowed to attach and before flooding the wells with 
media. Micromass culture allowed us to establish conditions that enable, rather than 
drive, chondrogenesis and so suitably test our candidate metabolite.  
 
Considering osteogenesis first, for cells seeded on to coverslips with CS added, 
expression of the mature bone-specific proteins osteocalcin and osteopontin were 
noted at similar levels to those observed in osteoinductive media for both pericytes 
(Fig 3a) and MSCs (Fig 3c) compared to negligible expression in controls. For 
pericytes and MSCs, measured expression of osteopontin was greater than un-
stimulated control and similar to use of osteoinductive media (Figs 3b & d). 
Measurement of aggregated osteocalcin rich nodules revealed that mean nodule 
area was larger for pericytes treated with CS than osteoinductive media (Figure 3b) 
and it is noteworthy that no nodules were detected on untreated (no metabolite 
added) control. Image analysis of percentage of pericytes associated with 
osteocalcin rich nodules were 15.0±7.4% and 8.9±7.9% for CS and osteoinductive 
media respectively (no difference, p=0.1) compared to 0% for control (p<0.05). This 
illustrates comparable osteogenic differentiation between CS and osteoinductive 
media. Use of alizarin red staining for calcium in bone mineral (apatite, a calcium 
phosphate) also showed formation of nascent nodules when MSCs were treated 
with CS (Fig 3d). This was confirmed at transcript level with pericytes using primers 
for osteopontin and osteocalcin (Supplemental Fig 9a). 
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For pericytes and MSCs seeded (as micromass cultures) onto glass coverslips with 
GP18:0 added, similar expression of the cartilaginous proteins collagen II and 
aggrecan were noted to that of induction with chondrogenic media (Fig 3 e-g) and 
for MSCs, SOX9 expression was also shown to be enhanced (Fig 3h). This was 
confirmed at transcript level with pericytes using primers for collagen II and 
aggrecan (Supplemental Fig 9b).  
 
 
Illustration of regenerative potential of bioactive metabolites. 
Bioactive metabolites, such as those identified herein, could be drug candidates that 
influence metabolic pathways. We focus on CS as the candidate that fitted to well 
known canonical pathways in IPA® (likely because information on metabolite 
interactions is only emerging). As described, pathway analysis implicates CS with 
BMP signalling (Fig 5a, supplemental Fig 7). We hypothesise that CS could potentially 
be used as a much simpler alternative to BMP2 (the clinical standard) to provide 
enhanced osteogenesis. BMP2 signalling occurs through activation of the SMAD 
(SMA small body size and MAD mothers against decapentaplegic) pathway. 
Comparison of active (phosphorylated) SMAD 1 and 5 normalised to total SMAD 1 
and 5 shows activation of the pathway with addition of CS (Fig 5b). Further, if BMP 
signalling is antagonised with noggin then CS fails to stimulate osteogenesis (Fig 5b).  
 
To test effect of CS in a 3D tissue mimic in order to more closely resemble the in vivo 
situation, we formed a collagen gel and injected into it pericytes within the 40 kPa 
hydrogel with and without CS and cultured for 28 days (illustrated in Fig 5c). After 
culture without CS, three out of five tissue mimics were positive for extensive 
mineralisation as shown by von Kossa stain for phosphate. However, with CS, all five 
gels supported mineralisation and typically to a greater extent than using gel 
guidance alone (Fig 5c); this illustrates the potential ability of CS to mediate robust 
osseointegration in 3D. Such strategies could be important where ossification of soft 
tissues would be desirable, e.g. ossification of the masseter muscle in maxillofacial 
reconstruction of the jaw. 
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Discussion. 
In these experiments we have shown that the use of metabolomics analysis coupled 
to simple tissue stiffness matched supramolecular hydrogels can be used to exploit 
stem cells’ environmental adaptation processes for identification of novel bioactive 
metabolites that can define stem cell fate. Furthermore, individual bioactive 
metabolites were demonstrated to have similar efficiency to the complex cocktails of 
soluble factors currently used (e.g. dexamethasone with glycerophosphate and 
ascorbate for osteogenesis or dexamethasone, insulin and TGF-β1 for 
chondrogenesis) at a fraction of the cost.  
 
We have discussed the potential for CS as an osteoinductive drug due to its better-
known pathway. However, we note that GP18:0 may also have potential clinical use 
such as in matrix assisted autologous chondrocyte implantation (MACI) and has been 
developed for repair of osteoarthritic defects44. 
 
To conclude, this study demonstrates new methodology that uses designed 
supramolecular gels to allow for the facile identification of biological molecules that 
could be used to unlock the regenerative potential of stem cells. For the first time, 
the natural adaptation of stem cells to their physical environment was used to guide 
us to bioactive metabolite drug candidates. Peptide gels with simple composition 
and tuneable physical properties were developed specifically for stem cells to 
facilitate targeted differentiation and pericytes and MSCs were used as potential 
autologous stem cell sources. Into the future, this new approach could find further 
use in personalised medicine. In this scenario, a patient’s stem cells would be 
analysed using biomaterials for bioactive metabolites during differentiation of the 
fate desired clinically. Thus, highly effective bioactives could be identified for optimal 
regeneration of that patient. 
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Experimental Procedures. 
 
Materials 
Fmoc-Serine (Fmoc-S) was purchased from Bachem Ltd., UK, with purity > 99.5%. Cell 
culture inserts for 12-well and 24 well multiwell plates with 1.0 µm pore size were 
purchased from Greiner bio-one, UK. 
 
Synthesis of Fmoc-F2 
To a stirred solution of Fmoc protected L-Phenylalanine (1 equivalent) in 
dimethylformamide (DMF), coupling agent N,N,N’,N’-Tetramethyl-O-
(1Hbenzotriazol-1-yl)uronium hexafluorophosphate (HBTU) (1.2 equivalents) was 
added and stirred for 15 minutes. Then, hydrochloride salt of the C-terminal 
protected tert-butyl ester of L-Phenylalanine (1.2 equivalents) was added to the 
reaction mixture followed by addition of an organic base, diisopropylethyl amine (2.5 
equivalents). Then the coupling reaction was allowed to stir for overnight. Solvent 
was evaporated out and the reaction mixture was dissolved in ethyl acetate. The 
ethyl acetate layer was washed with 1N sodium bicarbonate solution as well as 1N 
hydrochloric acid solution to remove any excess acid or base, followed by saturated 
brine solution. The organic layer was dried over magnesium sulphate and the solvent 
was evaporated. The final products were purified by column chromatography using 
230-400 mesh silica gel as stationary phase and chloroform–methanol mixture as 
eluent.  
Then, deprotection of the tert-butyl group is carried out in 50:50 mixtures of 
dichloromethane (DCM) and trifluoroacetic acid (TFA) for overnight. Then excess TFA 
is removed followed by the crystallization of the product from ether. Final traces of 
TFA were removed by continuous washing with ether. Powder analysed by using 
HPLC and it shows more than 98% purity.  
 
Formation of the Fmoc hydrogels 
Samples were prepared by mixing Fmoc-F2 and Fmoc-S (Fmoc-F2/S) (1:1 ratio) in 10 
mL glass vials and suspending the powders to a specific peptide concentration in 
sterile/distilled H2O. 0.5 M NaOH was added dropwise until the powders were fully 
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dissolved. The vial was mixed with alternated vortexing and sonication and then 0.5 
M HCl was added until the desired pH was reached (7.5-7.8).  Prior to use Fmoc-F2/S 
pre gelation mixtures were sterilized under UV light for 45 min.  
To produce hydrogels from each of these pre-gelation mixtures, 300 µL were 
transferred to cell culture inserts in 12-well plates. A volume of 1400 µL of culture 
medium was added to each well (outside the insert) and incubated for 1 ½ hrs at 37 
°C in a humidiﬁed atmosphere with 5% CO2. Following gelation the medium 
surrounding the inserts was replaced and 300 µL of new medium was gently added 
to the surface of the gels. Following overnight incubation the pH of the gel stabilized 
at around pH 7.8 (±0.5).  
 
Fluorescence spectroscopy 
Fluorescence emission spectra were measured on a Jasco FP-6500 
spectrofluorometer with light measured orthogonally to the excitation light, with 
excitation at 280 nm and emission data range between 300 and 600 nm. The spectra 
were measured with a bandwidth of 3 nm with a medium response and a 1 nm data 
pitch. Experimental data were acquired in triplicate. 
 
Fourier transform infrared spectroscopy (FTIR) 
FTIR spectra were acquired in a Bruker Vertex spectrometer with a spectral 
resolution of 2 cm-1 and averaging 56 interferograms for each measurement. Gels 
were made in salt solution (DMEM, containing salts, for example, calcium chloride: 
200mg/L; potassium chloride: 400 mg/L; sodium chloride: 6800 mg/L; magnesium 
sulfate: 97.7 mg/L; di-sodium hydrogen phosphate: 140 mg/L; sodium bicarbonate: 
850 mg/L), made in D2O. The samples were transferred into a standard IR cell holder 
(Harrick Scientific) and contained between two CaF2 windows (thickness 2 mm) 
separated by a 25 μm PTFE spacer. D2O (99.9 atom % D, Aldrich) was used as the 
solvent for all the IR measurements.  
 
Rheology 
To assess the mechanical properties of the hydrogels, dynamic frequency sweep 
experiments were carried out on a strain-controlled rheometer (Kinexus rotational 
15 
 
rheometer from Malvern) using a parallel-plate geometry (20 mm) with a 0.50 mm 
gap. An integrated temperature controller was used to maintain the temperature of 
the sample stage at 25°C. Precautions were taken to minimize solvent evaporation 
and to keep the sample hydrated: a solvent trap was used and the atmosphere 
within was kept saturated. To ensure the measurements were made in the linear 
viscoelastic regime, an amplitude sweep was performed and the results showed no 
variation in elastic modulus (G′) and viscous modulus (G″) up to a strain of 1%. The 
dynamic modulus of the hydrogel was measured as a frequency function, where the 
frequency sweeps were carried out between 1 and 100 Hz. The measurements were 
repeated at least three times to ensure reproducibility. 
 
Atomic force microscopy (AFM) 
For analysis of pre-gelation mixtures, 100 µL of mixture, prepared using the standard 
procedure described above, was placed on a trimmed, freshly cleaved mica sheet 
attached to an AFM support stub for 1 min. Upon removing any excess mixture by 
capillary action, the surface was rinsed twice with 200 µL of distilled H2O and left to 
air-dry overnight in a dust-free environment, prior to imaging. To image the hydrogel 
structure, media is removed and gels were placed on mica sheet for 1 min and rinsed 
twice with 200 µL of distilled H2O. The images were obtained by scanning the mica 
surface in air under ambient conditions using a Veeco MultiMode with NanoScope 
IIID Controller Scanning Probe Microscope (Digital Instruments, Santa Barbara, CA, 
USA; Veeco software Version 6.14r1) operated in tapping mode.  The AFM 
measurements were obtained using a sharp silicon probe (TESP; nominal length 
(lnom) = 125 µm, width (wnom) = 40 µm, tip radius (Rnom) = 8 nm, resonant frequency 
(υnom) = 320 kHz, spring constant (knom) = 42 N m-1; Veeco Instruments SAS, Dourdan, 
France), and AFM scans were taken at 512 x 512 pixels resolution. Typical scanning 
parameters were as follows: tapping frequency 308 kHz, integral and proportional 
gains 0.3 and 0.5, respectively, set point 0.5 – 0.8 V and scanning speed 1.0 Hz. The 
images were analyzed using Veeco Image Analysis software Version 6.14r1.  
 
Transmission electron microscopy (TEM) 
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Carbon-coated copper grids (No. 400) were glow discharged for 5 s and placed shiny 
side down on the surface of the pre gelation mixtures and hydrogels for less than 5 s. 
Excess sample was removed by blotting with a filter paper and then 10 mL of 
negative stain (Nanovan: 1% aqueous methylamine vanadate, obtained from 
Nanoprobes) was placed on the top of the sample on the grid and allowed to dry for 
10 mins. The dried specimens were then imaged using a LEO 912 energy filtering 
transmission electron microscope operating at 120 kV fitted with a 14 bit/2 K 
Proscan CCD camera. Fiber diameters were measured using ImageJ software version 
v1.43u.   
 
Static light scattering (SLS) 
Static light scattering measurements for pre-gelation mixtures were performed on 
3DDLS instrument (LS instruments, Fribourg, Switzerland) using vertically polarized 
He-Ne laser light (25 mW with wavelength of 632.8 nm) with an avalanche 
photodiode detector at angles between 15° and 135° at 25 °C. The scattering 
intensity patterns from static light scattering experiments were analyzed by applying 
Guinier’s law to calculate the shape-independent size parameter, radius of gyration 
(Rg).  
In the range of Q-values higher than Guinier’s region the scattering intensity can be 
described by power law:  
fdQQI

)(  
Where, Q is the scattering vector amplitude (Q = (4πn/λ)sin(θ/2) , n is the refractive 
index of the solvent and λ is the wavelength of the laser). At intermediate Q, the 
exponent df reflects the dimensionality of the scattering object which is for instance, 
1 for thin rod like particles. 
 
Interaction of Fmoc F2/S with fibronectin, vitronectin and serum proteins 
The interactions of Fmoc-F2/S fibers with different proteins fibronectin, vitronectin 
and serum protein in the concentration range relevant to cell culture conditions 
were characterized by Fluorescence based method as described previously45. The 
different concentrations of proteins were mixed with pre-gelation mixtures of Fmoc-
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F2/S and the quenching in emission fluorescence intensity was measured and the 
results are shown in Figures.  The binding constants were calculated by applying the 
model described previously45, 46. 
 
Pericyte isolation 
Pericytes were isolated from the adipose tissue of healthy adult donors undergoing 
cosmetic lipectomy procedures with prior written consent. Ethical approval for the 
collection of tissue and subsequent research was granted by the South East Scotland 
Research Ethics Committee 3 (SESREC03), reference number 10/S1103/45. Cells 
were purified to homogeneity by Flow Activated Cell Sorting (FACS) using a FACS Aria 
II (BD Biosciences) based on our established protocols47. Briefly, adipose tissue was 
enzymatically digested with type II collagenase (1mg/ml, Sigma-Aldrich) for 30 mins 
in a shaking waterbath at 37°C to obtain the Stromal Vascular Fraction (SVF). SVF 
was then stained with the following antibodies; CD146-Alexa647 (1:100, AbD 
Serotec, Raleigh, NC), CD45 APC-cy7, CD31-FITC, and CD34-PE (1:100, all from BD 
Biosciences, San Jose, CA). Pericytes were sorted to homogeneity based on the 
following phenotype CD146+, CD45-, CD34- and CD31-. Immediately following FACS, 
pericytes were seeded onto 0.1% gelatin coated wells at a density of 20,000 
cells/cm2 in EGM-2 media (Lonza) in a humidified incubator with 5% CO2 at 37°C. 
When confluent, cells were detached from the cultureware using 0.25% trypsin and 
split at a ratio of 1:6 into uncoated wells and cultured in DMEM+20% FCS for all 
subsequent passages. Media was changed 3 times per week. Purity of pericyte 
cultures was confirmed by flow cytometry. 
 
Cell Culture and Reagents 
For cell culture, after overnight incubation of the hydrogel at 37°C, the basic, or 
standard, culture media (DMEM (PAA Laboratories) supplemented with 10% v/v 
foetal bovine serum (FBS) and 2% v/v antibiotic mix (60% v/v L-Glutamine, 35% v/v 
penicillin streptomysin and 5% v/v Ampotericin B)) on the surface and around the 12 
well insert was removed. The media in the well was replaced with fresh media. The 
media on the surface of the gel was reﬁlled with 100 µL pericyte cell suspension with 
a cell density of 1 x 104 cells along with 200 µL of new media. Culture plates were 
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incubated under humidiﬁed atmosphere of 5% CO2 at 37°C. Basic media was 
replaced every 24 hours in the first two days of preparation and every other day 
after that. For seeding onto coverslips, cells (pericytes or MSCs purchased from 
Promocell GmbH (human, from bone marrow)) were seeded onto 13 mm glass 
coverslips at a density of 1 x 104 cells in 1 ml of complete media. 
Cells were cultured for times indicated in the figures. Briefly, for on gel PCR 1 week 
was used, for metabolomics 1 and 4 weeks were used, for directed differentiation 
using induction media and bioactive metabolites 3 weeks was used (4 weeks for von 
Alizarin red). 
Chondrogenic differentiation was induced using micromass culture48, 49 and DMEM 
containing 10% FBS, insulin (6.25 μg/ml), dexamethasone (100 nM), ascorbate-2-
phosphate (50 nM), transforming growth factor (TGF-β1, 10 ng/ml) and sodium 
pyruvate (110 μg/ml). Micromass cultures were performed by ‘spotting’ 20 μl 
droplets of cell suspensions into 24 well culture plates. These were then incubated 
for approximately 1.5 hrs to allow cell attachment. Following this, chondrogenic 
media was gently added to each well plate without disturbing the cells. Osteogenic 
differentiation was induced using complete DMEM containing 10% FBS, 
dexamethasone (100 nM) and ascorbate-2-phosphate (350 μM) on cells seeded as a 
suspension in 1 ml of media. 
Cholesterol sulphate (Sigma-Aldrich) and GP18:0 (Avanti polar lipids) stock solutions 
were made up in DMSO and subsequently serially diluted in complete medium to 
final concentrations of 1 µM for cholesterol sulphate and 0.1 µM for GP18:0. Care 
was taken to ensure that the final DMSO concentration in any of the working 
solutions was less than 0.2%. Cells were maintained in culture with each of the 
compounds, at each concentration, for the experiment duration. 
For all differentiation and metabolite test item cultures, the media was changed 
twice weekly for the duration the experiment                                             
 
Immunofluorescence cell staining 
After 3 weeks in culture (unless otherwise stated), the cells were washed once in PBS 
and fixed with 10% formaldehyde at 37°C for 15 min. When fixed, the samples were 
permeabilised using a buffer solution (10.3 g sucrose, 0.292 g NaCl, 0.06 g MgCl2, 
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0.476 g Hepes buffer, 0.5 ml Triton X, in 100 ml water, pH 7.2) at 4°C for 5 min. The 
samples were then incubated at 37°C for 5 min in 1% BSA/PBS, followed by the 
addition of the primary antibody (1:50 in 1% BSA/PBS, monoclonal anti-human 
osteopontin, osteocalcin, SOX-9, nestin, myoD, 3 tubulin and aggrecan raised in 
mouse (IgG1), Santa Cruz Biotechnology Inc) for 1h (37°C). Simultaneously, 
rhodamine conjugated phalloidin was added for the duration of this incubation 
(1:100 in 1% BSA/PBS, Invitrogen, UK). The samples were then washed in 0.5% 
Tween 20/PBS (5 min, x3). A secondary, biotin-conjugated antibody (1:50 in 1% 
BSA/PBS, monoclonal anti-mouse (IgG), Vector Laboratories, Peterborough, UK) was 
added for 1 h (37°C) followed by washing. A FITC conjugated streptavidin third layer 
was added (1:50 in 1% BSA/ PBS, Vector Laboratories, Peterborough, UK) at 4°C for 
30 min, and given a final wash. 
Samples were mounted onto a drop of DAPI (Vector Laboratories, Peterborough, UK) 
on a microscope slide then viewed using a fluorescence microscope (Zeiss Axiovert 
200M).  
Fluorescence microscopy images of cell components were overlayed using RGB stack 
in Image J (software v1.48, National Institute for Health, USA). Comparative analysis 
to quantify cell populations positively expressing gene markers and the areas relative 
areas with increased fluorescence intensities were also performed using 
threshold/contrast isolation in ImageJ to measure differences in expression level or 
to detect and count a cell component 
 
Alizarin red staining 
Cells maintained in culture for 3 weeks were washed with PBS and fixed with 10% 
formaldehyde for 20 minutes. Following this, cells were washed with sterile water 
and incubated with alizarin red solution (8.3 mM, pH 4.2) for 1 hr at room 
temperature. Cells were then washed until clear with sterile water and stored in 
sterile water for microscopy. 
 
QRT-PCR analysis 
For figure 1, RNA extractions from cells cultured on hydrogel biomaterials and tissue 
culture controls for 1, 2 or 4 week were done using the Trizol extraction reagent 
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(Invitrogen).  For figures 3 and 4, cells cultured for 3 weeks on culture well plastic 
had RNA retrieved using RNeasy micro kit (Qiagen), both protocols were carried out 
as per manufacturers instructions. Reverse transcription to obtain cDNA was done 
using Quantitech reverse transcription kit (Qiagen) for all samples, also according to 
the manufacturers protocol. 
Amplification by qRT-PCR was done using human specific primers for Glut-4, collagen 
type II, osteopontin, nestin, β3-tubulin and GFAP (Eurofins MWG Operon) detailed in 
table 1. PCR was carried out using a 7500 Real time PCR system & software (Applied 
Biosystems). Samples had a total reaction volume of 20 µl containing 2 µl of diluted 
cDNA, each reverse and forward primer at a final concentration of 100 µM and 
analysed using SYBR green chemistry (Qiagen). For PCR amplification samples were 
held at 50°C for 2 minutes then 95°C for 10 min then amplified using 95°C for 15 s 
and 60°C for 1 min for 40 cycles. The specificity of the PCR amplification was checked 
with a heat dissociation curve (measured between 60 – 95°C) done subsequent to 
the final PCR cycle. Gene expression levels were standardised using GAPDH as an 
internal control. Quantification analysis was performed using the comparative ΔΔCt 
method50 and gene expression expressed as fold change relative to the control 
sample. 
Samples were assayed in quadruplicate and gene expression was expressed as mean 
± SEM. 
 
Table 1. Real time PCR primers used to quantify mRNA expression from human genes. 
Gene   
Glut-4 
Forward 5’-ATG TTG CGG AGG CTA TGGG-3’ 
Reverse 5’-AAA GAG AGG GTG TCC GGT GG-3’ 
PPAR-γ 
Forward 5’-TGT GAA GCC CAT TGA AGA CA-3’ 
Reverse 5’-CTG CAG TAG CTG CAC GTG TT-3’ 
SOX-9 
Forward 5’-AGA CAG CCC CCT ATC GAC TT-3’ 
Reverse 5’-CGG CAG GTA CTG GTC AAA CT-3’ 
Collagen type II 
(Col2a1) 
Forward 5’-CACC TGG GAC TGT CCT CTG CGA-3’ 
Reverse 5’-CCT TTG GTC CTG GTT GCC CAC T-3’ 
Aggrecan (ACAN) 
Forward 5’-TAC ACT GGC GAG CAC TGT AAC-3’ 
Reverse 5’-CAG TGG CCC TGG TAC TTG TT-3’ 
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RUNX-2 
Forward 5’-GGT CAG ATG CAG GCG GCC-3’ 
Reverse 5’-TAC GTG TGG TAG CGC GTC-3’  
Osteopontin (OPN) 
Forward 5’-AGC TGG ATG ACC AGA GTG CT- 3’ 
Reverse 5’-TGA AAT TCA TGG CTG TGG AA -3’ 
MyoD 
Forward 5’-CAC TAC AGC GGC GAC TCC-3’ 
Reverse 5’-TAG GCG CCT TCG TAG CAG-3’ 
Myogenin 
Forward 5’-GCT CAG CTC CCT CAA CCA-3’ 
Reverse 5’-GCT GTG AGA GCT GCA TTC G-3’ 
Nestin 
Forward 5’-GTG GGA AGA TAC GGT GGA GA-3’ 
Reverse 5’-ACC TGT TGT GAT TGC CCT TC-3’ 
β3-tubulin 
Forward 5’-CAG ATG TTC GAT GCC AAG AA -3’ 
Reverse 5’-GGG ATC CAC TCC ACG AAG TA-3’ 
GFAP 
Forward 5’-GCT TCC TGG AAC AGC AAA AC-3’ 
Reverse 5’-AGG TCC TGT GCC AGA TTG TC-3’ 
GAPDH 
Forward 5’-ACC CAG AAG ACT GTG GAT GG-3’ 
Reverse 5’-TTC TAG ACG GCA GGT CAG GT-3’ 
 
 
Metabolomic analysis 
Metabolite extraction from cells cultured on hydrogels and control samples at 1 and 
4 weeks were carried out on ice using ice cold chloroform:methanol:water 
(1:3:1,v/v). Samples were agitated on a shaker for 1 h and maintained at 4°Cfor this 
duration. Samples were centrifuged to sediment the debris and the supernatant 
transferred to clean eppendorf tubes.10 μL of the supernatant was subsequently 
injected on to the LC-MS system. 
The LC separation was carried out using hydrophilic interaction chromatography 
with a ZIC-HILIC 150 mm x 4.6 mm, 5 μm column (Merck Sequant), operated by an 
UltiMate liquid chromatography system (Dionex, Camberley, Surrey). The LC mobile 
phase was run with 0.1% formic acid in water (A) and 0.08% formic acid in 
acetonitrile (B). The mobile phase was run at a linear gradient for 30 minutes from 
20% - 80% A, maintained at 5% A for 10 minutes and then re-equilibrated to 20% A. 
Mass spectrometric detection was performed using an Orbitrap Exactive (Thermo 
Fisher Scientific, Hemel Hempstead, U.K.) within the mass range m/z 70 – 1400 in 
polarity switching mode. 
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Chromatographic peak selection and metabolite identification were done using 
Ideom/MzMatch excel interface51, 52, measured peak intensities by LC-MS were 
normalised against protein content as measured using the Bradford assay as detailed 
previously53. Metabolite identification was done using a set of known standards to 
define mass and chromatographic retention times. Putative metabolites were also 
identified on this basis using predicted retention times as described by Creek et al54. 
 
SMAD Analysis 
Promocell MSCs were cultured in complete media with a cell density of 1x104 cells 
per 13 mm diameter coverslip for 3 days. Cells were then treated with CS with final 
concentration of 1 µM for CS and 0.1% for DMSO for 2 days. Control samples were 
treated with DMSO only with final concentration of 0.1% for the last 2 days cell 
culture. In cell Western (ICW) was carried out for the detection of pSMAD 1/5. Cells 
were fixed on coverslips using 4% formaldehyde fixative buffer at 370C for 15 mins, 
and then permeabilised in cold methanol at 40C for 5 mins. Cells were then blocked 
in a 1% buffer (non-fat dry milk powder in 0.1% PBST (PBS with 1% Tween 20) buffer) 
at room temperature for 2 hours followed by 3 x 10 mins PBST washing. Cells were 
then incubated with p-SMAD 1/5 (Cal No: S463/465, Cell Signalling) and SMAD 1/5 
(Cal No: D5907/D462, Cell signalling) separately at 40C for overnight. The primary 
antibodies were diluted 1:100 in blocking buffer. After 3x10 mins washes with PBST 
buffer, cells were incubated with 1:5000 diluted infrared labelled secondary 
antibody IRDye 800CW (Cal No: 926-32211, LI-COR) and 1:500 diluted CellTag 700 
Stain (Cal No: 926-41090, LI-COR) at room temperature for 1 hour, and followed by 
3x10 mins washes with PBST. The coverslips were then dried before infrared 
scanning using the LI-COR Odyssey infrared imaging system. 
 
BMP2 antagonist treatment 
Human noggin protein (Sigma, UK) was dissolved in double processed tissue culture 
H2O to a final concentration of 5 ng/μL. Cells were seeded onto glass coverslips in 
basal medium, and after allowing cells to settle down on the substrates, 10 μL 
noggin solution was added to half the wells to produce a final concentration 50 
ng/mL. Cells were cultured in the presence of noggin for 5 days, then the medium 
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was replaced with fresh medium without noggin for the rest of the culture period. 
After 21 days, cells were fixed and stained for osteocalcin and osteopontin as 
described previously. 
 
Collagen tissue mimic culture 
1 ml of type I collagen (First Link, UK, from rat tail) was cast in ThinCert tissue culture 
inserts within 12 well plates. For each 3 mls of collagen, 0.5ml 10x DMEM, 0.5ml FCS, 
2.5ml collagen and 1ml 0.1M NaOH were mixed. 0.1 M NaOH was added drop-wise 
until the colour changed to red. The wells flooded with complete media as the gels 
set. A 70 mM Fmoc hydrogel solution was prepared as has been described and 1x 
105 pericytes per ml of hydrogel solution were added. 1 ml of the pre-gelation/cell 
mix was injected into the collagen gels and cultured for 28 days. Cells were fed twice 
weekly with complete media or cholesterol sulphate (0.1 µM concentration) 
supplemented media. At the end of the culture, von Kossa staining for mineralisation 
was used. Gels were immersed in a 5% silver nitrate solution and each side of the 
hydrogel was exposed to UV light for 30 minutes. The solution was removed and gels 
washed with deionised water before addition of 5% sodium thiosulphate for 30 
minutes. Samples were next washed under running water for 10 minutes. Hydrogels 
were counterstained with nuclear fast red for 10 minutes, and again solution 
aspirated to waste and rinsed with deionised water. Samples were rinsed in 70% 
ethanol for 10 minutes and then maintained in 1 x PBS solution until ready to be 
imaged. 
 
Statistical Analysis 
Analysis of variance (ANOVA) and Bonferroni post hoc tests were performed using 
GraphPad prism software to compare more than two study groups. Otherwise, an 
unpaired, two-tailed students t-test was carried out. Statistical significance is noted 
where the calculated p value is less than 0.05. 
 
Images and data available from: http://dx.doi.org/10.5525/gla.researchdata.224 
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Figure Legends. 
 
Figure 1. Self-assembly of two-component gelators and analysis of primary pericyte 
differentiations. (a) Schematic presentation of proposed core-shell nanostructures. 
(b) AFM images of Fmoc-F2, Fmoc-S and the 50:50 mixture. Structures of Fmoc-F2 and 
Fmoc-S are shown in supplemental Fig 1l. (c) Fluorescence emission spectra show a 
sharp peak at 320nm corresponding to monomeric emission of the fluorenyl moiety, 
with an broad peak at 460-480 nm due to the formation of aggregated excimers. The 
peak at 380 nm for Fmoc-S indicates the differential fluorenyl organisation upon 
formation of spherical aggregates (Supplemental Fig 1B). (d) FTIR spectra of Fmoc-F2 
show a band (1625-1640 cm-1) due to the peptide amide I modes that are consistent 
with a well-ordered β-sheet-like arrangement and a second band at 1687 cm-1 which 
relates to the ordered carbamate moiety. For Fmoc-S, a carboxylate peak is evident 
at 1590 cm-1 which loses intensity and broadens in the mixture of the two 
components, consistent with co-assembly. (e) Oscillatory rheology of the gels show 
elastic moduli of different concentration gels. Results show that the stiffness 
increases when the concentration increases.  (f) Macroscopic images for 10, 20, 40 
mM gels in culture media. Pericytes were assessed for the expression of (g) 3 tubulin 
(neural cells), (h) SOX-9 (chondrocytes) and (i) RUNX2 (osteoblasts) on each hydrogel 
type with primary expression of 3 tubulin being observed on the 2 kPa (soft) surface, 
SOX-9 on the 15 kPa (stiff) surface and RUNX2 on the 40 kPa (rigid) surface after 1 
week of culture. It is important to note that cells were only cultured in basal media 
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with no differentiation enhancing factors and so differentiation is purely substrate 
driven. Stats by ANOVA and Bonferroni post hoc test; control was pericytes on glass 
coverslips with standard media, * p < 0.05 & *** p < 0.001. Error bars = standard 
error from the mean; n = 4 material replicates for PCR. Note that other marker 
transcripts were tested for and are shown in supplemental figure 3 to confirm this 
analysis. 
 
Figure 2. Identification of candidate metabolites with roles in lineage specific 
differentiation. After 1 and 4 weeks of pericyte culture on the hydrogels, whole 
metabolome analysis (LC-MS) was performed and from the whole metabolome, lipids 
were selected as a group with distinct changes where depletions were abundant. 
From the lipids, selected depletions for each stiffness - (a) stiff (15 kPa) and (b) rigid 
(40 kPa) - were identified (arrows from heatmaps to bar charts). Analysis of average 
peak intensities of the metabolites GP18:0 and cholesterol sulphate (CS) measured 
after 1 and 4 weeks in culture is illustrated as bar charts with significant depletions 
noted in pericytes on stiff and rigid gels respectively. Each metabolite was observed 
as having depletive characteristic particular to substrate stiffness, suggesting 
lineage-specific demand (i.e. GP 18:0 in chondrogenesis and CS in osteogenesis). 
When these metabolites were placed within their KEGG pathways of glycerolipid and 
steroid biosynthesis using stacked bar charts, the ‘hit’ metabolites were seen to be 
major depletions (each metabolite is shown at 1 week (1W) and 4 weeks (4W) of 
culture). Stats by ANOVA and Bonferroni post hoc test. For individual lipid plots, * p < 
0.05 & *** p < 0.001. For KEGG plots, § denotes significant depletion on the stiff gel 
and # denotes significant depletion on the rigid gel. Error bars = standard error from 
the mean; n = 3 material replicates. A.u. = arbitrary units. Please note that log scale 
graphs are used. 
Figure 3. Testing of biological molecule driving of osteogenesis and chondrogenesis. 
(a-d) For osteogenic assays, cells were cultured for 3 weeks with standard media, 
media containing CS or osteo-indictive media (OIM) prior to testing. (a) Pericytes and 
(c) MSCs were cultured in either osteogenic inductive media (OIM) or 1μM CS and 
demonstrated increased expression of the osteogenic markers osteopontin and 
osteocalcin appearing in nodule-like formations (arrows) with addition of CS similar 
to that of OIM. (b) For pericytes, image analysis of osteocalcin and osteopontin 
staining showed signifincant increase in expression for both osteoblast-related 
proteins with use of OIM or CS enhanced media from use of standard media alone 
and analysis of bone nodule area from alizarin red histology for showed nodules to 
be larger with CS than with OIM. (d) For MSCs, image analysis of osteopontin 
staining showed signifincant increase in expression for the osteoblast-related protein 
with use of OIM or CS enhanced media from use of standard media alone and alizarin 
red stain for calcium illustrated appearance of bone nodules appearing in MSCs 
cultures treated with CS (arrows). For chondrogenic assays (e-h), cells were 
maintained using micromass culture for 10 days without/without the addition of 0.1 
µm GP18:0 or chondro-inductive media (CIM) prior to testing. Collagen II (Col II – 
pericyte) or SOX9 (MSC) and aggrecan (ACAN) expression was noted in pericyte (e) 
and MSC (g) cultures with either chondro-inductive media (CIM) or GP18:0 but not on 
control coverslips with basal media (arrows). Image analysis showed significantly 
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increased expression of both aggrecan and collagen II with addition of CIM and 
GP18:0 with pericytes (f) and increased expression of SOX9 and aggrecan with MSCs 
(h). Error bars = standard deviations. For PCR n=4 replicates, for image analysis data 
is obtained from >120 cells from 4 replicates. Stats by ANOVA followed and 
Bonferroni post-hoc test; * p < 0.05 & ** p < 0.01. Control was pericytes/MSCs on 
glass coverslips with standard media. Fluorescence images show actin cytoskeleton 
(red), cell nuclei (blue) and SOX9, collagen II, aggrecan, osteocalcin or osteopontin 
(green). A.u. = arbitrary units. Note that PCR analysis of the marker transcripts is 
shown in supplemental figure 10 to validate the protein data in this figure. 
 
Figure 4. Testing of cholesterol sulphate mechanism. (a) Layering metabolomics data 
with canonical biochemical pathways using Ingenuity pathway analysis showed CS 
interacting with TGF linked to BMP signalling. (b) Testing SMAD 1 & 5 activation 
(phosphortylation) by in cell Western analysis after 5 days of culture on glass 
coverslips showed significant up-regulation of SMAD phosphorylation with addition 
of CS compared to use of standard media and addition of noggin (CSn) prevented CS 
inducement of osteocalcin and osteopontin transcripts after 21 day culture as shown 
by qPCR. (c) Use of the 40 kPa hydrogel loaded with pericytes injected into a collagen 
tissue mimic produced a degree of mineralisation within the gels after 28 days of 
culture as shown by von Kossa histology. However, addition of CS produced 
consistent, high levels of mineralisation within the gels indicating the potential of 
biomaterials/bioactive metabolite strategies (note the small images are similarly 
contrast enhanced so that the difference between non mineralised and mineralised 
areas are clear). For metabolomics and quantitative analysis, n=3 material replicates, 
stats by ANOVA followed and Bonferroni post-hoc test; * p < 0.05. 
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